CPT code 46500 covers sclerotherapy for internal hemorrhoids, specifically injection of a sclerosing solution into the submucosa beneath a hemorrhoid to reduce blood flow and induce shrinkage. This minimally invasive procedural code is commonly used in ambulatory and office-based settings and is a frequent alternative to more invasive hemorrhoid treatments for appropriate candidates. Nationally, the code is relevant for outpatient surgical workflows, prior authorization pathways, and payer coverage policies that differentiate between conservative, office-based procedures and facility-based interventions.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for sclerotherapy, benchmarks for typical sites of service, and how payers commonly categorize this service for coverage and billing. The publication outlines coding considerations, common modifiers reported with procedural services (input provided), and areas where documentation supports medical necessity.

The report is intended for billing professionals, clinicians who perform hemorrhoid procedures, and policy analysts seeking clarity on mapping procedure use across payer policies. It summarizes the clinical purpose of the procedure, where it is typically performed, and the payer landscape relevant to CPT code 46500. Data not available in the input is noted where applicable.